Key findings

Newer, more targeted radiotherapy to regional nodes (vs no regional node radiotherapy) cuts distant recurrence by 14% and breast cancer mortality by 13%, with no effect on nonbreast cancer mortality, according to a meta-analysis by an international team (the Early Breast Cancer Trialists' Collaborative Group) in The Lancet ...